CA45422-3A - 0x00000000000067A6
Healthy Males & Females
Alchemy
* Stipend may pay up to reflected amount.
Start Date:
November 6, 2025 - 7:30am
End Date:
February 26, 2026 - 8:00am
Study Details
Study Number: CA45422
Group Number: 3A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $10,500.00
Study Criteria
Age: 19 - 65
BMI: 18 - 32
Weight Restriction: minimum weight 110 lbs
Study Information
Indication: This investigational medication is being developed to treat ALS (often called Lou Gehrig's disease) which causes muscle weakness and paralysis.
Route of Administration: Injection IV infusion
Blood Draws: 22
Study Schedule
Schedule Type: Short stays with returns
Study Length: 4- Night Stay, 6 Returns & 1 Phone Call
Screening Dates (appointments available in Lincoln and Omaha):
Event Day | Event Date |
---|---|
Friday | 10/24/2025 |
Friday | 10/31/2025 |
Monday | 11/3/2025 |
Doctor Exam Dates (appointments available in Lincoln and Omaha):
Event Day | Event Date |
---|---|
Friday | 10/24/2025 |
Friday | 10/31/2025 |
Monday | 11/3/2025 |
Study Dates:
Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
---|---|---|---|---|---|---|
Return | Thursday | 11/6/2025 7:30:00 AM | Thursday | 11/6/2025 8:30:00 AM | 1L | Lincoln |
Check-In | Wednesday | 11/12/2025 1:30:00 PM | Sunday | 11/16/2025 8:00:00 AM | 1 | Lincoln |
Phone participant | Thursday | 11/20/2025 11:00:00 AM | 1 | Lincoln | ||
Return | Wednesday | 11/26/2025 7:00:00 AM | Wednesday | 11/26/2025 8:00:00 AM | 1 | Lincoln |
Return | Wednesday | 12/10/2025 7:00:00 AM | Wednesday | 12/10/2025 8:00:00 AM | 1 | Lincoln |
Return | Friday | 1/9/2026 7:00:00 AM | Friday | 1/9/2026 8:00:00 AM | 1 | Lincoln |
Return | Thursday | 1/29/2026 7:00:00 AM | Thursday | 1/29/2026 8:00:00 AM | 1 | Lincoln |
Return | Thursday | 2/26/2026 7:00:00 AM | Thursday | 2/26/2026 8:00:00 AM | 1 | Lincoln |